Cargando…

P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB

Detalles Bibliográficos
Autores principales: Duminuco, Andrea, Mosquera-Orgueira, Adrian, Nardo, Antonella, Raimondo, Francesco DI, Palumbo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431325/
http://dx.doi.org/10.1097/01.HS9.0000971084.17982.f2
_version_ 1785091174453739520
author Duminuco, Andrea
Mosquera-Orgueira, Adrian
Nardo, Antonella
Raimondo, Francesco DI
Palumbo, Giuseppe
author_facet Duminuco, Andrea
Mosquera-Orgueira, Adrian
Nardo, Antonella
Raimondo, Francesco DI
Palumbo, Giuseppe
author_sort Duminuco, Andrea
collection PubMed
description
format Online
Article
Text
id pubmed-10431325
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104313252023-08-17 P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB Duminuco, Andrea Mosquera-Orgueira, Adrian Nardo, Antonella Raimondo, Francesco DI Palumbo, Giuseppe Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431325/ http://dx.doi.org/10.1097/01.HS9.0000971084.17982.f2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Duminuco, Andrea
Mosquera-Orgueira, Adrian
Nardo, Antonella
Raimondo, Francesco DI
Palumbo, Giuseppe
P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
title P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
title_full P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
title_fullStr P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
title_full_unstemmed P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
title_short P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
title_sort p1047: aipss-mf machine learning model as useful prognostic score compared to ipss in the setting of myelofibrosis patients treated with ruxolitinib
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431325/
http://dx.doi.org/10.1097/01.HS9.0000971084.17982.f2
work_keys_str_mv AT duminucoandrea p1047aipssmfmachinelearningmodelasusefulprognosticscorecomparedtoipssinthesettingofmyelofibrosispatientstreatedwithruxolitinib
AT mosqueraorgueiraadrian p1047aipssmfmachinelearningmodelasusefulprognosticscorecomparedtoipssinthesettingofmyelofibrosispatientstreatedwithruxolitinib
AT nardoantonella p1047aipssmfmachinelearningmodelasusefulprognosticscorecomparedtoipssinthesettingofmyelofibrosispatientstreatedwithruxolitinib
AT raimondofrancescodi p1047aipssmfmachinelearningmodelasusefulprognosticscorecomparedtoipssinthesettingofmyelofibrosispatientstreatedwithruxolitinib
AT palumbogiuseppe p1047aipssmfmachinelearningmodelasusefulprognosticscorecomparedtoipssinthesettingofmyelofibrosispatientstreatedwithruxolitinib